Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • DLR vs GSK✓SelectedUSD · GSKDLR vs GSK performance historyLatest closeAs of-2.41%11/19
Stock and ETF performance explorer

DLR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+40.2%
GSK return
+53.5%
Excess return
-13.3%
Maximum drawdown
-29.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.4%-1.6%-0.8%-2.3%
7D-5.2%-4.7%-0.4%-4.8%
30D-0.7%-4.7%+4.0%-0.4%
3M-8.9%-8.8%-0.2%-8.2%
6M-5.3%-4.6%-0.7%-5.0%
YTD+14.8%+1.0%+13.8%+15.0%
1Y+12.4%+6.9%+5.5%+12.2%
All+40.2%+53.5%-13.3%+34.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling